Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 3
2010 3
2011 3
2012 3
2013 4
2014 4
2015 5
2016 2
2017 1
2018 2
2019 2
2020 1
2021 5
2022 6
2023 8
2024 9
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Technology-aided recreation and communication opportunities for post-coma persons affected by lack of speech and extensive motor impairment.
Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Buonocunto F, Sacco V, Navarro J, Lanzilotti C, D'Amico F, Sasanelli G, De Tommaso M, Megna M. Lancioni GE, et al. Among authors: megna m. Res Dev Disabil. 2013 Sep;34(9):2959-66. doi: 10.1016/j.ridd.2013.06.006. Epub 2013 Jun 29. Res Dev Disabil. 2013. PMID: 23816631 Clinical Trial.
Immunopharmacology of the main herbal supplements: a review.
Amico AP, Terlizzi A, Damiani S, Ranieri M, Megna M, Fiore P. Amico AP, et al. Among authors: megna m. Endocr Metab Immune Disord Drug Targets. 2013 Dec;13(4):283-8. doi: 10.2174/1871530314666140123152024. Endocr Metab Immune Disord Drug Targets. 2013. PMID: 24456264 Review.
Clinical Onset of Action of Incobotulinum Toxin A Preparation.
Marvulli R, Ranieri M, Rizzo LB, Marra F, Ianieri G, Megna M. Marvulli R, et al. Among authors: megna m. CNS Neurol Disord Drug Targets. 2023;22(6):916-923. doi: 10.2174/1871527321666220630154404. CNS Neurol Disord Drug Targets. 2023. PMID: 35786195
62 results